FDA NDC
Baxdela
This name is from the loaded FDA file.
Source: FDA NDC Directory, live from openFDA. Publisher page
- NDC
- 70842-102
- Proprietary name
- Baxdela
- Nonproprietary name
- delafloxacin meglumine
- Labeler
- Melinta Therapeutics, LLC
- Dosage form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Strength
- 300 mg/10.5mL
HCPCS J0349 Billable units per 11-digit NDC: 200.